“Polysubstance” is not a diagnosis. DSM-5 removed it in 2013, and clinicians are now required to identify and code each substance use disorder separately. If your records list three diagnoses where you expected one, that is the current standard working correctly.
That sounds like paperwork and is not. Separate diagnoses force a separate answer for each substance — and those answers are not interchangeable. Two of them can kill you on the way out; two of them cannot. Alcohol and benzodiazepine withdrawal carry seizure risk. Opioid withdrawal is brutal and rarely lethal on its own. Stimulant withdrawal is not medically dangerous at all, and has no approved medication.
So the first clinical question is never “which is the main one”. It is which one has to be handled first, and under what supervision.
- The diagnosis you are searching for no longer exists. DSM-5 (2013) removed polysubstance dependence. You now receive one diagnosis per substance, each with its own severity and its own treatment.
- Risk multiplies rather than adds. Among synthetic-opioid overdose deaths in 2016, almost 80% involved another drug or alcohol. Combinations that suppress breathing do so together, at doses that would each be survivable alone.
- The order is decided by danger, not by amount. Alcohol and benzodiazepines come first because their withdrawal can cause seizures. That is true even when they are not the substance you are most worried about.
- Some of the combination was never chosen. Illicitly manufactured fentanyl now appears in supplies people believe are something else, and xylazine appears alongside it — which is why naloxone helps with part of an overdose and not all of it.
- Three problems need three treatments, run together. Medication for opioid use disorder, a supervised taper for sedatives, and a behavioural programme for stimulants are not alternatives to each other.
of synthetic-opioid overdose deaths in 2016 involved another drug or alcohol
Source: CDC, Polysubstance Overdose
of cocaine-involved overdose deaths in 2017 also involved an opioid
Source: CDC, Polysubstance Overdose
share of overdose deaths involving both fentanyl and a stimulant, 2010 to 2021
Source: Charting the Fourth Wave, 2023
the year DSM-5 removed polysubstance dependence as a diagnosis
Source: DSM-5 / APA
Why there is no polysubstance diagnosis any more
DSM-5 removed it in 2013, and the reason is worth knowing if you are looking up a code. Under DSM-III-R and DSM-IV, “polysubstance dependence” described a specific and unusual situation: three or more substances used together where the criteria for dependence were met collectively but no single substance met them on its own. ICD-10 defined a similar category in 1992 for cases where it was unclear which substance contributed most.
Why it was retired
Because that precise picture turned out to be rare, while the label was being applied to almost everyone using more than one substance — including people who plainly met the criteria for two or three separate disorders. A single vague label replaced three specific ones, and specificity is what treatment is built on.
What replaced it
Each substance is now assessed and coded on its own, with its own severity. Someone drinking daily, taking a prescribed benzodiazepine and using a stimulant receives three diagnoses — and, correctly, three different treatment answers.
Why the word survives anyway
It persists in clinical language largely for practical reasons: it is embedded in electronic health record systems, addiction medicine training is uneven, and there is no agreed nomenclature for describing multiple-substance use. So you will still see it on paperwork, in referral letters and in coding lookups — ICD-10’s F19 category is commonly used where substances are not separately coded.
The practical point for a reader: if a programme describes you as “polysubstance” and stops there, ask which disorders it has actually diagnosed. The answer should be a list, not a category.
Why combining substances multiplies risk instead of adding it
Because the substances act on the same systems, and the effects compound rather than sum. This is the part that turns two survivable doses into one fatal event.
Depressants together
Alcohol, benzodiazepines, Z-drugs and opioids all suppress the drive to breathe. Taken together they suppress it more than either quantity would predict, and the person is usually asleep while it happens. This combination is behind a large share of accidental deaths involving prescribed medicines.
Stimulants with opioids
A stimulant masks sedation. Someone feels less affected than they are, redoses, and the opioid effect remains once the stimulant fades. The figures follow: 72.7% of cocaine-involved overdose deaths in 2017 also involved an opioid, and the share of overdose deaths involving both fentanyl and a stimulant rose from 0.6% in 2010 to 32.3% in 2021.
The number that frames all of it
Among synthetic-opioid-involved overdose deaths in 2016, almost 80% involved another drug or alcohol. Single-substance overdose is the exception in this data, not the rule — which is exactly why treating one substance and ignoring the others is not a conservative approach but a risky one.
The order that matters: which withdrawal can kill you
Sequence is decided by danger, not by which substance feels like the main problem. This is the single most useful thing on this page, and it is the question most first calls get wrong.
First: alcohol and sedatives
Alcohol withdrawal in its severe form produces seizures and delirium tremens and can be fatal without treatment. Benzodiazepine and Z-drug withdrawal carries seizure risk too, documented even after short courses at prescribed doses. If either is present, medical supervision comes first — regardless of how modest the amount looks next to everything else.
Alongside: opioids
Opioid withdrawal is severe and rarely lethal by itself. The danger sits on either side of it: dehydration during, and collapsed tolerance after — a dose that was routine three weeks ago can be fatal on return. This is precisely why medication for opioid use disorder is started rather than waiting for withdrawal to finish.
Alongside: stimulants
Stimulant withdrawal is not medically dangerous. What it produces is exhaustion, heavy sleep and anhedonia, and the real risk in that window is depression and suicidal thinking. There is no approved medication; the treatment with the strongest evidence is contingency management.
What this means in a real plan
Everything does not stop at once. A competent plan stabilises the dangerous withdrawal under supervision, starts medication where it applies, and holds the behavioural work for the substance that has no medication — concurrently, not in a queue. A programme that proposes stopping everything simultaneously without naming which withdrawal it is monitoring has not read your case.
Write down everything, including the legal ones
Every substance, the amount, and how long. Alcohol counts. Prescribed medication counts. The list decides the plan, and an incomplete list produces a plan for somebody else.
Establish which withdrawal is dangerous
Alcohol and sedatives can cause seizures and need medical supervision. Opioid withdrawal is severe and rarely lethal alone. Stimulant withdrawal is not medically dangerous. This single sort decides the sequence.
Stabilise the dangerous one under supervision
Withdrawal management or a supervised taper first, with the other substances addressed alongside rather than after. Nothing about this step requires a month away from your life.
Start the treatments that differ by substance
Medication for opioid use disorder, a paced taper for sedatives, a behavioural programme for stimulants, and medication plus therapy for alcohol. These run concurrently — they are not alternatives.
Treat what the combination was solving
Pain, insomnia, trauma, ADHD, depression. A combination usually assembled itself for a reason, and leaving the reason untreated is how a second attempt gets scheduled.
Withdrawal risk by substance — the order this dictates
| Substance | What withdrawal does | Where it sits in the order |
|---|---|---|
| Alcohol | Tremor, sweating and insomnia early; seizures and delirium tremens in the severe form, which can be fatal without treatment | First — medical supervision |
| Benzodiazepines and Z-drugs | Rebound anxiety and insomnia, sensory disturbance, and seizures — reported even after short courses at prescribed doses | First — supervised taper |
| Opioids | Severe flu-like illness, cramps, vomiting, restlessness and intense craving. Dangerous mainly through dehydration and through the collapsed tolerance that follows | Alongside — medication available |
| Stimulants | Exhaustion, heavy sleep, large appetite, anhedonia and depressed mood. Not medically dangerous; the risk is depression and suicidal thinking | Alongside — behavioural treatment |
Key takeaway: If alcohol or a benzodiazepine is anywhere on your list, step two is not optional. Both can produce seizures on abrupt withdrawal, and both are routinely left off the list because one was prescribed and the other is legal.
The combination you did not choose
Some polysubstance exposure happens without the person’s knowledge, and it has changed what an overdose looks like.
Fentanyl in things that are not sold as fentanyl
Illegally manufactured fentanyl now appears in supplies people believe to be something else entirely. The consequence in the data is direct: in 2020 roughly 40% of deaths involving illegally made fentanyls also involved a stimulant, and by 2023 nearly 70% of stimulant-involved overdose deaths involved illegally manufactured fentanyl.
Xylazine
Xylazine — a veterinary sedative, not an opioid — increasingly appears alongside fentanyl. By June 2022 it was detected in 11% of fentanyl deaths. Naloxone reverses the opioid part of that overdose and not the xylazine part, which is why breathing may not fully recover after naloxone and why emergency care is still needed.
What follows practically
Carry naloxone and use it even when opioids are not the expected substance; call emergency services regardless of response; and treat “I only used one thing” as a statement about intention rather than about what was in the body. An honest intake asks what you took and what you might have taken.
What treatment looks like when there are three answers at once
Three problems get three treatments, delivered together rather than in sequence. The failure mode here is a programme that treats the substance it is set up to treat and refers the rest away.
Opioids: medication, started early
Buprenorphine, methadone and naltrexone are approved, and the evidence for the first two on survival is stronger than for anything else in this field. Medication is compatible with treating other substances at the same time.
Sedatives: the taper is the treatment
For benzodiazepines and Z-drugs there is no approved medication for the dependence itself. A slow, individually paced reduction is the intervention, and it does not have to be finished before other work starts.
Stimulants: behavioural, and specifically
No approved medication exists. Contingency management has the strongest evidence, and it is unevenly available — a fair question to ask any programme by name rather than by category.
Alcohol: medication plus therapy
Approved medications exist and are under-used. Where alcohol sits alongside other substances, its withdrawal governs the early schedule and its treatment continues well past that point.
The thread through all four
Whatever was underneath — pain, insomnia, trauma, ADHD, depression — usually explains why the combination assembled itself in the first place. Treating four substances and none of the reasons is how people arrive at a second attempt. Compare the levels of care on our levels of care page, and the medication options under medication-assisted treatment.
Polysubstance treatment cost: standard vs luxury, by setting
| Setting | Standard | Luxury / executive |
|---|---|---|
| Assessment establishing every substance involved | Often covered in full | Included |
| Medically supervised withdrawal (alcohol or sedatives present) | $500–$1,500 per day | $1,000–$2,500 per day |
| Structured outpatient covering more than one substance | $3,000–$10,000 per course | $10,000–$25,000 per course |
| Residential where withdrawal risk and home environment both apply | $15,000–$40,000 per month | $40,000–$90,000 per month |
2026 U.S. self-pay estimates; insurance reimbursement varies. Figures indicate relative cost, not a Peninsula quote.
When the second substance is alcohol
This is the most common version of the situation and the least often named. A prescribed medication plus a nightly drink is not what people picture when they hear “polysubstance”, and it is the pattern that fills assessments.
With a benzodiazepine or Z-drug
Both suppress breathing and both impair memory; together they do more of each than the amounts suggest. This is also the combination where withdrawal needs supervision on both counts at once, and where stopping the drink but keeping the tablet leaves the seizure risk in place.
With an opioid painkiller
Alcohol amplifies respiratory depression and the sedative effect. Regular use of both is a leading route to accidental overdose in people who never considered themselves at risk, because neither dose felt unusual.
With a stimulant
Alcohol’s sedation is masked; more is drunk than intended and the effect arrives later. Cocaine and alcohol together also form cocaethylene in the liver, a compound with its own cardiac risk.
Why people leave it out at intake
Because it was prescribed, or because it is legal, or because it is normal in their circle. An assessment that does not ask directly will not hear about it, and the level of care will then be set against an incomplete picture. If you are reading this and doing the arithmetic quietly, that is the thing worth saying out loud on the first call: (844) 595-3264.
This page is information, not medical advice
This page is information, not medical advice. If alcohol or a benzodiazepine is one of the substances involved, do not stop abruptly without medical supervision. Do not begin or stop medication, or attempt to detox, without a qualified physician. If you are physically dependent, stopping abruptly can be dangerous — seek medical supervision. For immediate help call SAMHSA 1-800-662-HELP, or 911 in an emergency.
Frequently asked questions about using more than one substance
What is the ICD-10 code for polysubstance use disorder?+
F19 is the ICD-10 category commonly used — “other psychoactive substance related disorders” — where substances are not coded separately. It is worth knowing why the question is awkward: DSM-5 removed polysubstance dependence as a diagnosis in 2013, so there is no current DSM entity for it. Best practice is to code each substance use disorder individually, with its own severity, because that is what determines treatment.
Is polysubstance use disorder still a diagnosis?+
Not in DSM-5. It existed in DSM-III-R and DSM-IV for an unusual case — three or more substances meeting dependence criteria collectively while no single substance met them alone. That picture was rare, while the label was being applied broadly, so it was removed in 2013 in favour of separate diagnoses. The term survives in clinical speech mainly because it is embedded in electronic records and there is no agreed replacement vocabulary.
Which substance should be treated first?+
The one whose withdrawal is dangerous, which is almost always alcohol or a benzodiazepine — even where it is not the substance causing the most disruption. Opioid withdrawal is severe but rarely lethal alone, and medication can be started early. Stimulant withdrawal carries no medical danger. A programme should be able to tell you which withdrawal it is monitoring and why, before you admit.
Can I stop everything at once?+
Not safely, if alcohol or a benzodiazepine is involved — abrupt cessation of either can cause seizures. The safe version stabilises the dangerous withdrawal under supervision while other substances are addressed alongside it. Stopping everything simultaneously without supervision is the single most common way this goes wrong at home.
Does naloxone work if more than one drug is involved?+
It reverses the opioid component and only that. If xylazine is present — detected in 11% of fentanyl deaths by June 2022 — breathing may not fully recover after naloxone, and if a stimulant or alcohol is involved those effects continue unchanged. Give naloxone anyway, then call emergency services and stay: naloxone treats part of what is happening, not all of it.
Do I need residential treatment because more than one substance is involved?+
Not automatically. The number of substances is one input; the decision still runs on the ASAM dimensions — withdrawal risk, medical and psychiatric conditions, previous attempts, and whether home supports stopping. What multiple substances usually do change is the need for medical supervision at the start, which is a different question from where you sleep for the following month.
Will using several substances make treatment less likely to work?+
It makes an incomplete plan much more likely to fail, which is not the same thing. The predictable failure is treating one substance well and the others not at all — the untreated one reinstates the pattern. Where each disorder is addressed with the intervention that fits it, and the underlying condition is treated too, outcomes are not the poor relation people expect.
What if I am not sure what I actually took?+
Say exactly that. Supplies are frequently not what they are sold as, and clinicians work with uncertainty routinely — it changes monitoring rather than acceptance. Guessing confidently is worse than saying you do not know, because the withdrawal plan is built on the answer. A clinician will work through it with you on (844) 595-3264.
Other substances we treat
Sources & references
- CDC — Polysubstance overdose (prevention, combinations, data)
- Rethinking the use of “polysubstance” to describe complex substance use patterns (PMC)
- Charting the fourth wave: polysubstance fentanyl overdose deaths, 2010–2021 (PubMed)
- NIDA — Drug overdose deaths: facts and figures
- ASAM — About the ASAM Criteria (how level of care is decided)
- SAMHSA TIP 45 — Detoxification and substance abuse treatment (NCBI Bookshelf)
- CDC — About overdose prevention
- SAMHSA — National Helpline (free, confidential, 24/7)
Reviewed September 2026 · Peninsula editorial standards.
A single discreet conversation.
A master's-level clinician answers. Twenty-five minutes establishes whether medically supervised detox is needed, what level of care fits, and whether Peninsula is right for you.